carbogen has been researched along with Local Neoplasm Recurrence in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Anzela, A; Azzopardi, M; Barrett, S; Buddle, N; Hooshmand, R; Knesl, M; Min, M; Notman, A; Vignarajah, DD; Wilson, J; Woolls, H | 1 |
Denekamp, J; Fowler, JF | 1 |
Beck-Bornholdt, HP; Krüll, A; Raabe, A; Rett, M | 1 |
Kaanders, JH; Liefers, J; Marres, HA; Pop, LA; van Daal, WA; van den Hoogen, FJ; van der Kogel, AJ | 1 |
1 review(s) available for carbogen and Local Neoplasm Recurrence
Article | Year |
---|---|
ARCON--current status: summary of a workshop on preclinical and clinical studies.
Topics: Animals; Carbon Dioxide; Cell Division; Cell Hypoxia; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Experimental; Niacinamide; Oxygen; Oxygen Consumption; Radiation-Sensitizing Agents; Radiobiology; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Regional Blood Flow; Urinary Bladder Neoplasms | 1997 |
3 other study(ies) available for carbogen and Local Neoplasm Recurrence
Article | Year |
---|---|
Concurrent carbogen and nicotinamide with radiation therapy in muscle invasive bladder cancer: A report on feasibility in the Australian setting.
Topics: Aged; Australia; Carbon Dioxide; Feasibility Studies; Humans; Muscles; Neoplasm Recurrence, Local; Niacinamide; Oxygen; Urinary Bladder Neoplasms | 2021 |
Combination of fractionated irradiation with nicotinamide and carbogen in R1H-tumours of the rat and its pulmonary metastases.
Topics: Animals; Carbon Dioxide; Combined Modality Therapy; Disease Models, Animal; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Female; Lung; Lung Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Experimental; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Rats; Rhabdomyosarcoma; Skin Neoplasms; Treatment Outcome | 1997 |
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.
Topics: Actuarial Analysis; Administration, Inhalation; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma; Cell Division; Cell Hypoxia; Dose Fractionation, Radiation; Feasibility Studies; Female; Follow-Up Studies; Humans; Laryngeal Neoplasms; Laryngectomy; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Niacinamide; Oxygen; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy Dosage; Salvage Therapy; Survival Rate | 1998 |